Amphastar Pharmaceuticals (AMPH) Property, Plant & Equipment (Net) (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.19 Bn | 87.33 Bn | - | 37.35 Bn |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 4.00 Bn |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | 3.72 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | 13.52 Bn |
| 5 | United Therapeutics | 23.22 Bn | 21.07 Bn | 648.10 Mn | 1.84 Bn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | 49,000.00 |
| 7 | Viatris | 20.29 Bn | 18.48 Bn | 1.16 Bn | 2.53 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn | 90.90 Mn |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 1.40 Bn |
| 10 | Amphastar Pharmaceuticals | 864.29 Mn | 693.15 Mn | 70.32 Mn | 378.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 378.91 Mn |
| Mar 31, 2026 | 378.91 Mn |
| Dec 31, 2025 | 353.72 Mn |
| Dec 31, 2025 | 353.72 Mn |
| Sep 30, 2025 | 308.69 Mn |
| Sep 30, 2025 | 308.69 Mn |
| Jun 30, 2025 | 354.73 Mn |
| Jun 30, 2025 | 354.73 Mn |
| Mar 31, 2025 | 307.60 Mn |
| Mar 31, 2025 | 307.60 Mn |
| Dec 31, 2024 | 297.35 Mn |
| Dec 31, 2024 | 297.35 Mn |
| Sep 30, 2024 | 327.52 Mn |
| Sep 30, 2024 | 327.52 Mn |
| Jun 30, 2024 | 288.00 Mn |
| Jun 30, 2024 | 288.00 Mn |
| Mar 31, 2024 | 893.25 Mn |
| Mar 31, 2024 | 893.25 Mn |
| Dec 31, 2023 | 282.75 Mn |
| Dec 31, 2023 | 282.75 Mn |